Corporate News: Eurofins Scientific Trading Update

Eurofins Scientific (ERF.PA) finished the trading session on Friday, 23 October 2026, with its share price up 2.41 % at 04:12 PM Central European Time. At the close, one share was priced at approximately €84.32 on the primary exchanges. The market currently supplies 176 million shares of Eurofins Scientific, which translates into a market capitalisation of €14.2 billion. In the preceding 24 hours, the company’s securities were traded for roughly €41.9 million. Over the past month, the share price has increased by 2.46 %, and the 200‑day simple moving average sits at €67.93. The highest price reached during the last 52 weeks was €82.16 on 21 October 2026, while the 52‑week low stood at €54.86 on 21 November 2025.

Regulatory Disclosure of Share Acquisitions

Eurofins Scientific announced that several senior personnel have completed the regulatory disclosure of share acquisitions under the European Market Abuse Regulation. The transactions involve shares of Eurofins Scientific itself, purchased by Analytic Bioventures S.C.A., a subsidiary controlled by Eurofins. The disclosed purchases were executed at prices around €79 per share, with volumes ranging from 500 to 1,140 shares. Filings dated 19‑21 October 2026 provide detailed information on transaction dates, prices, and volumes, and are accessible through Eurofins’ investor‑relations portal.

Market Performance of Peer Companies

RTL Group (RRTL.DE)

RTL Group remained flat at 0 % during the 24‑hour period, trading at €31.5. Its market capitalisation is €4.7 billion, with a price‑to‑earnings ratio of 202.48. The Frankfurt Stock Exchange closed in decline, with the MDAX falling nearly two percent to its lowest level of the day. Among the constituents, RTL Group’s shares were the only ones that rose modestly, reflecting a small uptick in investor sentiment toward the broadcaster. Other performers included Sartorius, Aroundtown, and freenet, while several semiconductor and industrial stocks experienced significant losses. The market’s overall trend remains negative, as the MDAX has slipped more than three percent since the start of the year, despite reaching a yearly high earlier in the year.

Globant (GLOB)

Globant’s shares rose 5.97 % to USD 44.88, with a market capitalisation of USD 1.9 billion and a price‑to‑earnings ratio of 16.85.

Cpi Property (O5G.DE)

Cpi Property remained flat at 0 % and trades at EUR 0.74. Its market capitalisation is EUR 6.6 billion.

Ardagh Metal Packaging (AMBP)

Ardagh Metal Packaging’s shares fell by 0.43 % to USD 4.63. The company’s market capitalisation is USD 2.7 billion, and its price‑to‑earnings ratio is 88.51. The company reported its third‑quarter 2026 results on 22 October, posting adjusted earnings broadly in line with the previous year’s quarter. Global shipment volumes grew modestly, driven by a rise in Europe, while the Americas experienced a slight decline. The board approved a quarterly interim dividend of 10 cents per ordinary share, payable on 10 December to shareholders of record on 26 November. The company highlighted ongoing investment plans in Europe to support customer demand and noted a stable cash and liquidity position, with a net debt to adjusted earnings ratio that had improved compared with the prior year. The results were accompanied by a management discussion and a scheduled earnings webcast for investors.

Reinet Investments Sca (REINA.AS)

Reinet Investments Sca’s shares rose 1.56 % to €24.03. The company’s market capitalisation is €4.7 billion.

About Eurofins Scientific

Eurofins Scientific SE, through its subsidiaries, provides a broad spectrum of analytical testing services worldwide. The company’s portfolio encompasses approximately 200,000 analytical methods that evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as clinical diagnostics. Eurofins serves diverse sectors, including agri‑science, agri‑testing, biopharma, contract development and manufacturing organizations, clinical diagnostics, consumer product testing, cosmetics testing, digital testing, electrical and electronics, environmental testing, food and feed testing, forensic, genomic, industrial, materials and engineering, medical devices, and REACH services. With operations in around 800 laboratories across 47 countries, Eurofins was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. Additional information about the company and its services can be found on its website at www.eurofins.com . Eurofins Scientific is publicly traded on the NYSE Euronext Paris.